Friday, October 15, 2010; 7:30am - 1:00pm
Anschutz Medical Campus (L28-2001 Bridge & L28-1102 Lecture Hall)
View Program (PDF)
Breakfast, lunch and afternoon networking reception included.
This program will showcase and highlight the impact of the university's research enterprise on society, clinical practice, the economy and the environment, emphasizing the applied, translational and commercial aspects.
The retreat will assemble a distinguished group of translational scientists and clinicians, faculty entrepreneurs and members of the business community to discuss and celebrate entrepreneurship at the University of Colorado Denver. The retreat will serve as a way to take time out and share some of the success stories and impacts of UCD research with legislators, the business community, and other key stakeholders, and bring some much-deserved attention to faculty entrepreneurs who have seen their research put to use to make a difference.
- Margie McGlynn; former Vice President, Merck Vaccines
- Timothy Rodell, MD; CEO, GlobeImmune Inc.
- Holli Baumunk; CEO, Colorado BioScience Association
- Ron Sokol, MD; Vice-chair of Pediatrics; co-director, CCTSI
- Richard Duke, PhD; CEO, CID4; founder of GlobeImmune, ApopLogic, PeptiVir.
RSVP requested by October 8 to Trudy Boudreau: 303-724-1039, email@example.com. A map of Anschutz Medical Campus is available here.
Attendees should plan to park in Julesburg lot East of Ed. II. The parking fee is $5.